| PTO Form 1581 (Rev 9/2005) |
| OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
| SERIAL NUMBER |
78971555 |
| LAW OFFICE ASSIGNED |
LAW OFFICE 104 |
| MARK SECTION |
| STANDARD CHARACTERS |
YES |
| USPTO-GENERATED IMAGE |
YES |
| LITERAL ELEMENT |
CIALIS |
| OWNER SECTION (current) |
| NAME |
ELI LILLY AND COMPANY |
| STREET |
LILLY CORPORATE CENTER |
| CITY |
INDIANAPOLIS |
| STATE |
Indiana |
| ZIP/POSTAL CODE |
46285 |
| COUNTRY |
United States |
| PHONE |
317-651-1346 |
| FAX |
317-276-1919 |
| OWNER SECTION (proposed) |
| NAME |
ELI LILLY AND COMPANY |
| STREET |
LILLY CORPORATE CENTER |
| CITY |
INDIANAPOLIS |
| STATE |
Indiana |
| ZIP/POSTAL CODE |
46285 |
| COUNTRY |
United States |
| PHONE |
317-651-1346 |
| FAX |
317-276-1919 |
| EMAIL |
XXXX |
| GOODS AND/OR SERVICES SECTION |
| INTERNATIONAL CLASS |
005 |
| CURRENT IDENTIFICATION |
Pharmaceutical preparations for the treatment and prevention of hypertension, urological diseases and disorders, and benign prostate
hyperplasia |
| GOODS OR SERVICES |
KEEP ALL LISTED |
| EXTENSION SECTION |
| EXTENSION NUMBER |
3 |
| ONGOING EFFORT |
product or service research development |
| ALLOWANCE MAIL DATE |
07/17/2007 |
| STATEMENT OF USE |
NO |
| PAYMENT SECTION |
| NUMBER OF CLASSES |
1 |
| SUBTOTAL AMOUNT |
150 |
| TOTAL AMOUNT |
150 |
| SIGNATURE SECTION |
| SIGNATURE |
/reljr44/ |
| SIGNATORY'S NAME |
Robert E. Lee, Jr. |
| SIGNATORY'S POSITION |
Assistant General Patent Counsel |
| DATE SIGNED |
12/04/2008 |
| FILING INFORMATION |
| SUBMIT DATE |
Thu Dec 04 12:12:31 EST 2008 |
| TEAS STAMP |
USPTO/ESU-XX.X.XX.XX-2008
1204121231714980-78971555
-40039a2947e078bff54ec64b
d7691669ed-DA-7919-200812
04112529614652 |
| PTO Form 1581 (Rev 9/2005) |
| OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: CIALIS
SERIAL NUMBER: 78971555
The applicant, ELI LILLY AND COMPANY, having an address of LILLY CORPORATE CENTER, INDIANAPOLIS, Indiana United States 46285, requests a six-month extension of time to file the Statement of Use under
37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 07/17/2007.
For International Class 005:
Current identification: Pharmaceutical preparations for the treatment and prevention of hypertension, urological diseases and disorders, and benign prostate hyperplasia
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: product or service research development
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /reljr44/ Date Signed: 12/04/2008
Signatory's Name: Robert E. Lee, Jr.
Signatory's Position: Assistant General Patent Counsel
RAM Sale Number: 7919
RAM Accounting Date: 12/04/2008
Serial Number: 78971555
Internet Transmission Date: Thu Dec 04 12:12:31 EST 2008
TEAS Stamp: USPTO/ESU-XX.X.XX.XX-2008120412123171498
0-78971555-40039a2947e078bff54ec64bd7691
669ed-DA-7919-20081204112529614652